Back to Feed
ClinicalTrials.gov|Clinical Trial
Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
Shenzhen Geno-Immune Medical Institute
Abstract
The purpose of this study is to assess the feasibility, safety and efficacy of mesenchymal stem cells (MSCs) in combination with CAR-T cells in treating autoimmune disease. Another goal of the study is to learn more about the safety and function of the MSCs combined with CAR-T cells and their long term effects in autoimmune disease patients. Phase: PHASE1, PHASE2 Status: RECRUITING Conditions: Autoimmune Diseases Interventions: fetal MSCs combined with 4SCAR T cells
Keywords
Autoimmune Diseases